Owens & Minor

Owens & Minor, Inc. engages in the provision of healthcare solutions. It operates through the Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Owens & Minor achieves record revenue, focuses on cost-saving initiatives

Owens & Minor's Q4 2022 performance reflects record revenue, strong segment growth, and strategic initiatives to drive profitability and operational efficiency.
While facing challenges in certain divisions, the company's focus on cost-saving programs and market competitiveness positions it well for future growth and success.
With a positive outlook for 2023, Owens & Minor aims to capitalize on opportunities for growth, cash flow improvement, and market expansion to drive shareholder value.

Owens & Minor reports solid Q1 results, raises 2023 outlook

Owens & Minor's Q1 performance reflects a mix of successes and challenges, with a strong focus on realignment and debt reduction. The company is optimistic about future growth prospects, particularly in the patient direct segment, and remains committed to enhancing operational efficiency and capital deployment.

Owens & Minor reports strong Q2 performance amidst PPE challenges

Owens & Minor's Q2 performance reflects positive momentum with growth in key segments and a focus on financial health through debt reduction.
Challenges in the PPE market and uncertainties in demand highlight the need for strategic planning and risk management strategies.
The company's strengths in revenue growth drivers and new business contracts position it well for future growth opportunities and financial success.

Owens & Minor (OMI) posts strong Q3 results, eyes growth opportunities

Owens & Minor (OMI) reported a solid Q3 performance with revenue growth, debt reduction, and operational efficiency driving financial resilience.
While facing challenges in market visibility and regulatory changes, the company remains well-positioned to capitalize on growth opportunities and enhance shareholder value.
Strategic focus on key segments and profitability improvement initiatives set a positive trajectory for future growth and value creation.
Investors can look forward to sustained performance and profitability as Owens & Minor navigates challenges and seizes growth opportunities in the evolving healthcare landscape.

Owens & Minor (OMI) reports robust Q4 earnings and outlines growth strategy for 2024

Owens & Minor (OMI) showcased strong financial performance in Q4 2023, with a positive outlook for 2024. Despite challenges in EBITDA calculations and deal delays, the company remains focused on strategic investments and operational optimization.

Owens & Minor (OMI) reports robust Q1 performance and growth outlook

Owens & Minor (OMI) delivered strong financial performance in Q1 2024, driven by revenue growth and margin expansion initiatives despite challenges in cash flow and debt reduction.
The company's strategic focus on operational efficiency, cost reduction, and long-term investments positions it well for future growth and market opportunities.
With a solid foundation in place and a clear growth strategy, Owens & Minor (OMI) is poised to navigate challenges and leverage opportunities for sustained success.

Owens & Minor reports revenue growth and strategic acquisitions in Q2

Owens & Minor's Q2 performance showed revenue growth and improved operating income, despite a GAAP net loss.
The acquisition of Rotech Healthcare strengthens the Patient Direct segment, driving revenue growth.
Challenges include managing costs, addressing tariffs' impact, and balancing segment optimization with expansion.
Opportunities exist in leveraging acquisitions, expanding product offerings, and enhancing operational efficiency.

Owens & Minor reports solid Q3 performance and eyes growth

Owens & Minor demonstrated resilience and strategic focus in Q3 2024, with strong financial results and debt reduction achievements.
While facing challenges such as supply chain issues and tariff impacts, the company remains optimistic about growth opportunities.
Investors can look forward to the Rotech acquisition and the company's commitment to operational excellence and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Owens & Minor's diversified international presence and long-term agreements with clients ensure revenue stability and reduce volatility compared to smaller competitors. Recent acquisitions and R&D investments are expected to boost free cash flow and profitability, with a fair price target of $18 per share. The company's strategic use of cash for acquisitions, rather than shares, indicates undervaluation and confidence in future growth.

Owens & Minor: Very Undervalued Healthcare Business With Long-Term Agreements

Owens & Minor, Inc. (NYSE:OMI ) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Jackie Marcus - Investor Relations Edward Pesicka - President and Chief Executive Officer Jonathan Leon - Executive Vice President and Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Michael Cherny - Leerink Partners Allen Lutz - Bank of America John Stansel - JPMorgan Stephanie Davis - Barclays Eric Coldwell - Baird Daniel Grosslight - Citi Operator Good day, everyone, and thank you for standing by. Welcome to the Owens & Minor Third Quarter 2024 Earnings Conference Call.

Owens & Minor, Inc. (OMI) Q3 2024 Earnings Call Transcript

Owens & Minor (OMI) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.44 per share a year ago.

Owens & Minor (OMI) Q3 Earnings and Revenues Top Estimates

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2024. Key Highlights: Consolidated revenue of $2.7 billion in the third quarter, representing year-over-year growth of 5% GAAP Net loss of $(13) million or $(0.17) per share, and adjusted earnings per share of $0.42 in the third quarter Adjusted EBITDA of $142 million in the third quarter, representing year-over-year growth of 5% $198 million in total de.

Owens & Minor Reports Third Quarter 2024 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2024 on Monday, November 4, 2024, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All intere.

Owens & Minor Announces Third Quarter 2024 Earnings Release Date and Conference Call

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI), announced today that Mr. Jonathan Leon has been named Executive Vice President, Chief Financial Officer, effective immediately. Leon will maintain his corporate treasurer responsibilities while a search for his successor is underway. Mr. Leon has been with the Company since 2017, most recently serving as Interim Chief Financial Officer and Corporate Treasurer since June 2024. He will report directly to Mr. Edward Pesicka, Pres.

Owens & Minor Names Jonathan Leon Executive Vice President, Chief Financial Officer

Alphabet

OMI announces partnership with Google Cloud to enhance existing QSight capabilities.

Owens & Minor Stock to Gain From New Collaboration With Google Cloud

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor and Google Cloud are partnering to enhance the QSight clinical inventory management system for hospitals and health systems.

Owens & Minor Announces New Partnership with Google Cloud

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI), announced today that Ed Pesicka, the Company's President and Chief Executive Officer and Jon Leon, Corporate Treasurer and interim Chief Financial Officer, will participate in a fireside chat at 1:25 p.m. Eastern Daylight Time on Tuesday, September 10, 2024 at Baird's Global Healthcare Conference in New York City. Owens & Minor is also hosting one-on-one meetings with investors at the conference. About Owens & Minor Ow.

Owens & Minor to Present at the 2024 Baird Global Healthcare Conference

NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Did Owens & Minor, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- OMI

NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

OMI STOCK ALERT: Levi & Korsinsky Notifies Owens & Minor, Inc. Investors of an Ongoing Investigation

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Owens & Minor Being Investigated on Behalf of Owens & Minor, Inc. Investors. Contact Levi & Korsinsky For Details.

NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Shareholder Rights Advocates at Levi & Korsinsky Investigate Owens & Minor, Inc. (OMI) Regarding Possible Securities Fraud Violations

NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Lost Money on Owens & Minor, Inc. (OMI)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Owens & Minor, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - OMI

LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Investors With Losses In Owens & Minor Inc. Urged To Participate In Fraud Investigation Led By The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Owens & Minor Inc. Shareholders Invited To Join Fraud Investigation Led By The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Owens & Minor Inc. Investors Encouraged To Take Part In Fraud Investigation Led By The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Owens & Minor Inc. Shareholders Can Join In Fraud Investigation Led By The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Owens & Minor Inc. Investors Can Join Fraud Investigation Led By The Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Owens & Minor Inc. Shareholders Can Participate In Fraud Investigation Led By The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Owens & Minor Inc. Investors Able To Participate In Fraud Investigation Led By The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Owens & Minor Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Owens & Minor Inc Investors Eligible To Join Fraud Investigation With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / August 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. ("Owens & Minor" or "the Company") (NYSE:OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

News for Owens & Minor Stock (OMI)